E
EIKN
Eikon Therapeutics
7.47
-0.03-0.40%After Hours: 7.47 0.00 0.00%19:47 10/09 EDT
OPEN/PREV CLOSE7.48/7.50
TODAY RANGE7.25-7.82
VOL288.69K
MARKET CAP404.61M
52 WEEK RANGE7.02-17.40
AVG VOL (3M)497.94K
% TURNOVER0.49%
TURNOVER--
P/E (TTM)-1.3411
% RANGE7.60%
EPS(TTM)-5.5700
P/E(FORWARD)-1.0553
P/B0.8671
BVPS8.62
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP306.98M
SHARES OUTSTANDING54.17M
NEXT EARNINGS--
FREE FLOAT41.10M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·09/09 16:21
Inhibrx, Eikon rise after insider buying
TipRanks·09/09 02:06
Major Investor Makes Bold Move on Eikon Therapeutics Shares
TipRanks·09/03 11:40
Eikon Therapeutics appoints Ching-Pin Chang as chief scientific officer
Benzinga·08/25 14:03
Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday
Benzinga·08/19 14:08
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
TipRanks·08/17 12:58
Eikon Therapeutics, Inc. (EIKN) Receives a Buy from Morgan Stanley
TipRanks·08/16 13:25
Eikon Therapeutics price target lowered to $4 from $5 at Wedbush
Dow Jones·08/14 13:29
Eikon Therapeutics Price Target Cut to $4.00/Share From $5.00 by Wedbush
Dow Jones·08/14 13:29
Eikon Therapeutics Is Maintained at Underperform by Wedbush
Benzinga·08/14 13:21
Wedbush Maintains Underperform on Eikon Therapeutics, Lowers Price Target to $4
Simply Wall St·08/14 11:17
Possible Turnaround For Eikon Therapeutics Insiders, Still Down US$852k
TipRanks·08/14 10:35
Eikon Therapeutics Highlights Q3 2026 Oncology Pipeline Progress